{"data":[{"accessionNo":"0001104659-26-092212","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":9338010,"percentOfClass":7.2,"filedAt":"2026-08-06"},{"accessionNo":"0001104659-26-092212","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":9338010,"percentOfClass":7.2,"filedAt":"2026-08-06"},{"accessionNo":"0001104659-26-092212","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":9338010,"percentOfClass":7.2,"filedAt":"2026-08-06"},{"accessionNo":"0001104659-26-092212","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":7162923,"percentOfClass":5.5,"filedAt":"2026-08-06"},{"accessionNo":"0001386060-26-000050","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Boston Partners","reportingCik":null,"personType":"IA","sharesOwned":7635145,"percentOfClass":5.91,"filedAt":"2026-08-04"},{"accessionNo":"0002012383-26-001934","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":9356551,"percentOfClass":7.2,"filedAt":"2026-07-08"},{"accessionNo":"0001104659-26-063322","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-11","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":7872900,"percentOfClass":6.1,"filedAt":"2026-05-18"},{"accessionNo":"0001104659-26-063322","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-11","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":7872900,"percentOfClass":6.1,"filedAt":"2026-05-18"},{"accessionNo":"0001104659-26-063322","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-11","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":7872900,"percentOfClass":6.1,"filedAt":"2026-05-18"},{"accessionNo":"0001104659-26-063322","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-11","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":6974492,"percentOfClass":5.4,"filedAt":"2026-05-18"},{"accessionNo":"0001104659-26-041573","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-02","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":6638827,"percentOfClass":5.2,"filedAt":"2026-04-09"},{"accessionNo":"0001104659-26-041573","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-02","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":6638827,"percentOfClass":5.2,"filedAt":"2026-04-09"},{"accessionNo":"0001104659-26-041573","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-02","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":6638827,"percentOfClass":5.2,"filedAt":"2026-04-09"},{"accessionNo":"0000102909-26-001029","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001831915","issuerName":"Cytek Biosciences Inc","ticker":"CTKB","cusip":"23285D109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0001193125-25-284205","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":null,"securityClass":"Common Stock - $0.001 par value","eventDate":"2025-09-25","reportingPerson":"Topline Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":6780847,"percentOfClass":5.3,"filedAt":"2025-11-17"},{"accessionNo":"0001193125-25-284205","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":null,"securityClass":"Common Stock - $0.001 par value","eventDate":"2025-09-25","reportingPerson":"Collin McBirney","reportingCik":null,"personType":"IN,HC","sharesOwned":6780847,"percentOfClass":5.3,"filedAt":"2025-11-17"},{"accessionNo":"0001193125-25-284205","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":null,"securityClass":"Common Stock - $0.001 par value","eventDate":"2025-09-25","reportingPerson":"Topline Capital Partners, LP","reportingCik":null,"personType":"PN","sharesOwned":6780847,"percentOfClass":5.3,"filedAt":"2025-11-17"},{"accessionNo":"0001398344-25-020758","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001831915","issuerName":"Cytek Biosciences, Inc.","ticker":"CTKB","cusip":null,"securityClass":"Common Stock, $0.001 Par Value Per Share","eventDate":"2025-09-30","reportingPerson":"Brown Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":4958016,"percentOfClass":3.9,"filedAt":"2025-11-12"}],"updatedAt":"2026-10-15T01:50:58.141Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}